This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Global Intravenous Equipment Industry

Catheter II-45

Teleflex Recalls Arrow IV Tubing Sets and Arterial Embolectomy

Catheters II-45

Becton Dickinson Recalls IV, Catheter Products II-46

Baxter to Recall COLLEAGUE Infusion Pumps from the US Market II-46

9. CORPORATE ACTIVITY IN RECENT PAST - A PERSPECTIVE BUILDER II-47

Cardinal Health Spins Off Clinical and Medical Products Business II-47

Vesta Acquires ExtruMed II-47

Baxter Inks Distribution Agreement with Sigma International II-47

Access Scientific Inks Agreement with Teleflex Medical II-48

B. Braun Medical and Amerinet Ink Agreement II-48

Hospira and MedAssets Sign New Contracts II-48

MedPlast Expands Production Facility in Pennsylvania II-49

Flexicath Inks Distribution Deal with Sinopharm II-49

IH Systems to Deliver RIVA System to Mission Health for Off-

Site Pharmacy II-49

Arcomed AG Inks Partnership Agreement with Capsule Tech II-49

Medtronic Recalls Defective Quick-Set Infusion Sets II-50

Hospira Takes Over EndoTool Business Operations II-50

Tacpro Takes Over Catheter & Disposables Technology II-51

Bard Takes Over LifeStent Assets II-51

Parker Hannifin Acquires HTR Holding and Subsidiaries II-51

B. Braun Bags Specialty Infusion Pumps Contract from Novation II-51

Hospira Inks New Contracts with Premier Purchasing Partners II-52

Bard Acquires Specialized Health Products International II-52

Hospira Enters into Contract with HealthTrust II-52

B. Braun Acquires Exclusive Rights for CytoCare™ II-53

10. FOCUS ON SELECT PLAYERS II-54

Animas Corporation ( USA) II-54

Arcomed AG ( Switzerland) II-54

ASCOR S.A. ( Poland) II-54

B. Braun Melsungen AG ( Germany) II-55

Baxter International, Inc. ( USA) II-55

Baxa Corporation ( USA) II-55

Becton, Dickinson and Company ( USA) II-56

C.R. Bard Inc ( USA) II-56

CareFusion Corporation ( USA) II-57

Covidien plc ( Ireland) II-57

Fresenius Kabi AG ( Germany) II-58

Hospira, Inc. ( USA) II-58

I-Flow Corp. ( USA) II-58

Medical Technology Products, Inc. ( USA) II-59

Medtronic, Inc ( USA) II-59

Moog, Inc. ( USA) II-60

Roche Insulin Delivery Systems, Inc. (US) II-60

5 of 15

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 16,643.01 -11.76 -0.07%
S&P 500 1,988.87 +1.21 0.06%
NASDAQ 4,828.3250 +15.6170 0.32%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs